Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high120.000 19/10/16
52 week low9.525 19/07/17
52 week change -64.740 (-65.24%)
4 week volume13,080,778 21/09/17

Media for (AVO)

Presenter: Nicolas Serandour
05/09/2017

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Advanced Oncotherapy operating losses widen

Advanced Oncotherapy's operating losses rose to 7.3m in the six months to the end of June - up from 5.9m last time. Revenu...

Half-year Report

RNS Number: 1735S Advanced Oncotherapy PLC 29 September 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Half-year Report Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2017 and po...

Advanced Oncotherapy - Technological update

Technological update

RNS Number: 6608P Advanced Oncotherapy PLC 04 September 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Technological update Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it remains on schedule with the development of the first L...

Advance Oncotherapy - Interview with Gabriel Urwitz

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 31st July 2017 at a price of 17.75p. T...

Director Dealing

RNS Number: 6440M Advanced Oncotherapy PLC 01 August 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday Dr Enrico Vanni, Non-Executive Director of the Com...

Technological milestones update - CCL units

RNS Number: 5067M Advanced Oncotherapy PLC 31 July 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Technological milestones update - CCL units Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the completion of a further technological mil...

Fundamental DataMore

EPS-17.01
Dividend yield0 %

Latest discussion posts More

  • Re: Price rise

    Wow that's more than enough to cover the next few years and take them past live for Harley Street. I suppose it depends on how much they have to give away in equity, their ...
    6-Oct-2017
    fish lips
  • Re: Price rise

    Rumour of new funding - some say #100m new funding.
    6-Oct-2017
    Go Dink
  • Re: Price rise

    Had a look on their website and the was ...
    5-Oct-2017
    fish lips

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.20%
SIRIUS MINERALS15%
TESCO13%
ROYAL BANK SCOT12%
CENTRICA11%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO